| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SURG | Restricted Shares (Common Stock) | Award | $0 | +83.3K | +1.48% | $0.00 | 5.71M | Jul 1, 2024 | Direct | F1, F2 |
| transaction | SURG | Shares of Common Stock) | Sale | -$63.8K | -20.9K | -0.37% | $3.05 | 5.69M | Jul 2, 2024 | Direct | F3, F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Consists of an RSA grant in the amount of 83,333 set to vest on September 1, 2024. |
| F2 | Includes (i) 83,334 RSAs that vested on July 1, 2024, and (ii) 83,334 RSAs that are set to vest on each of August 1, and September 1, 2024. |
| F3 | The purpose of the sale is solely to cover taxes with vesting of restricted share awards. |
| F4 | Based upon shares sold at a high price of $3.11, a low price of $3.00, and an average of $3.0517. The full breakdown of the prices for all shares sold will be provided at the request of the SEC. |